116 results on '"Bourdin, Arnaud"'
Search Results
2. Outcomes and risk assessment in pulmonary veno-occlusive disease.
3. Early COPD and Hedgehog interacting protein (HHIP) polymorphisms
4. Characteristics of exacerbations in patients with severe, uncontrolled asthma who received tezepelumab versus placebo
5. Late Breaking Abstract - Development of a bronchial epithelium with a sensory innervation both derived from induced pluripotent stem cells
6. Phenotypic characterization of interstitial lung disease associated with mutations in SFTPC and ABCA3 in adults
7. High-dose aspirin in severe uncontrolled asthma associated with chronic rhinosinusitis with nasal polyps (CRwNP) : the ASTHMIRINE trial
8. Benefits of bronchial epithelial repair by iPSC in COPD
9. Blunted vascular response to pulmonary rehabilitation in COPD patients and impaired exercise-induced mobilization of endothelial-colony forming cells
10. Lower respiratory tract involvement in recurrent respiratory papillomatosis in a multicentric cohort study
11. Sputum viscosity is correlated with Computed Tomography (CT) mucus score in muco-obstructive lung diseases
12. An algorithm to identify patients with T2 diseases and Chronic Spontaneous Urticaria treated with biologics in outpatient care setting using a dynamic dispensing database
13. Construction of a 3D innervated bronchial epithelium from human induced pluripotent stem cells iPSC
14. Revisiting Peter Macklem's old dream through the PRISm of lung volumes.
15. Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma
16. Late Breaking Abstract - Second Souffle: preliminary results from a national survey on the care pathways and quality of life of patients with T2 severe asthma
17. Late Breaking Abstract - The burden of intermittent oral corticosteroid use in asthma
18. RCT Abstract - Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomized, double-blind, placebo-controlled, phase 3 trial
19. Role of stromal cells during human iPSC differentiation into bronchial epithelium
20. Late Breaking Abstract - Severe Asthma Prevalence, Care Pathways, and Health Care Resource Utilization in France
21. Effect of tezepelumab on exacerbation-related oral corticosteroid use in NAVIGATOR
22. Recognising the long-term burden of short course oral corticosteroids
23. Impact of COVID-19 on treatments’ dispensations for chronic airways diseases in France
24. Effect of tezepelumab on the proportion of exacerbation-free patients with severe, uncontrolled asthma in NAVIGATOR
25. Transcriptome profiling of platelets from patients with severe asthma
26. Chronic rhinitis
27. Targeted literature review: burden of disease associated with severe and uncontrolled asthma in France, Germany, Italy, Spain and the UK
28. Late Breaking Abstract - Biological determinants of sputum rheology in chronic airway diseases
29. Is CCL18 a potential biomarker of type-2 asthma?
30. Late Breaking Abstract - Dupilumab long-term safety and efficacy in patients with asthma: LIBERTY ASTHMA TRAVERSE
31. Targeted literature review: epidemiology of severe and uncontrolled asthma and associated biomarkers in France, Germany, Italy, Spain and the UK
32. Long-term outcomes in incident pulmonary arterial hypertension (PAH) patients initiated with triple combination therapy including parenteral prostacyclin (PGI2)
33. An expert statment on clinical considerations before treating NTM lung infection
34. Real-life experience with mepolizumab in the French early access program for severe eosinophilic asthma
35. Qualas: Quality of Life and burden in asthma, a comparison between uncontrolled severe asthma and controlled moderate/severe asthma
36. Systematic review and MAIC of OCS reduction with biologic asthma treatments
37. Differentiating asthma from chronic obstructive pulmonary disease (COPD) in medico-economic databases: myth or reality?
38. Expectations of patients suffering from idiopathic pulmonary fibrosis about their treatment: results of the French national survey, RESPIR
39. Protocol to identify potential severe asthma in UK primary care
40. A dynamic prognostic model to predict survival and determine treatment goals in pulmonary arterial hypertension (PAH): the EFORT study
41. Perception of the caregivers of patients with idiopathic pulmonary fibrosis: results of the French national survey, RESPIR
42. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety.
43. How can we minimise the use of regular oral corticosteroids in asthma?
44. Double gas transfer factors (TLNO/CO) in supine position discriminate congenital heart diseases from healthy adults.
45. Mucus rheology and ciliary beating coordination
46. Residual excessive sleepiness in long term CPAP-treated patients: a leak problem?
47. Differentiation of Induced Pluripotent Stem Cells (iPSC) into human bronchial epithelium from healthy and severe COPD patients.
48. Club cells in histological patterns of interstitial lung diseases
49. Supervising differentiation for tailoring the airway epithelial cell phenotype
50. Risk categories from European guidelines applied to the French Pulmonary Hypertension (PH) registry
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.